Minerva Surgical to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference
Minerva Surgical (Nasdaq: UTRS), a company focused on women’s health, announced its participation in the 33rd Annual Piper Sandler Virtual Healthcare Conference on December 1st.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Minerva Surgical (Nasdaq: UTRS), a company focused on women’s health, announced its participation in the 33rd Annual Piper Sandler Virtual Healthcare Conference on December 1st. This event will showcase the company’s innovations in treating Abnormal Uterine Bleeding (AUB). Interested parties can access the archived presentation for 90 days post-conference via Minerva's website.
Minerva specializes in minimally invasive solutions, aiming to reduce the need for hysterectomies by addressing common AUB issues.
Details
News Market Reaction – UTRS
The recorded move for UTRS in the trading session of this news was -5.28%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SANTA CLARA, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference on Wednesday, December 1st.
Interested parties may access the pre-recorded and archived webcast of the presentation for 90 days following the conference through the “Recent Events” section of Minerva’s website at http://ir.minervasurgical.com.
ABOUT MINERVA SURGICAL – THE UTERINE HEALTH COMPANY
Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The company has established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. The Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies.
MEDIA CONTACT
Mike Clapper
mike.clapper@minervasurgical.com
804-295-7676
INVESTOR RELATIONS CONTACT
Caroline Corner
investors@minervasurgical.com
415-202-5678
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.